{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:44:24Z","timestamp":1790621064990,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.coph.2022.102240","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T18:10:22Z","timestamp":1653329422000},"page":"102240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Disease-modifying therapies in short bowel syndrome"],"prefix":"10.1016","volume":"65","author":[{"given":"Brune","family":"de Dreuille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102240_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.clnu.2018.07.036","article-title":"Intestinal failure in adults: recommendations from the ESPEN expert groups","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0016-5085(99)70388-4","article-title":"Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome","volume":"117","author":"Messing","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102240_bib4","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1177\/0148607114525210","article-title":"Intestinal adaptation following resection","volume":"38","author":"Tappenden","year":"2014","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-nutr-011720-122203","article-title":"Short bowel syndrome: a paradigm for intestinal adaptation to nutrition?","volume":"40","author":"Le Beyec","year":"2020","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.clnu.2017.06.016","article-title":"Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure","volume":"37","author":"Joly","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clnu.2016.01.028","article-title":"Survival and nutritional dependence on home parenteral nutrition: three decades of experience from a single referral centre","volume":"36","author":"Dibb","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clnu.2012.08.007","article-title":"Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome","volume":"32","author":"Amiot","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2018-318172","article-title":"Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure","volume":"69","author":"Pironi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.coph.2022.102240_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14656566.2020.1724959","article-title":"Treating short bowel syndrome with pharmacotherapy","volume":"21","author":"Hollanda Martins Da Rocha","year":"2020","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.coph.2022.102240_bib11","first-page":"283","article-title":"Medical and surgical management of short bowel syndrome","volume":"155","author":"Billiauws","year":"2018","journal-title":"J\u00a0Vis Surg"},{"key":"10.1016\/j.coph.2022.102240_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2019.11.013","article-title":"Understanding short bowel syndrome: current status and future perspectives","volume":"52","author":"Massironi","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.coph.2022.102240_bib13","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00384-021-03863-4","article-title":"State-of-the-art colorectal disease: conservative surgical management of intestinal failure in adults","volume":"36","author":"Aubert","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.coph.2022.102240_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOT.0000000000000960","article-title":"Update on surgical management of enteroatmospheric fistulae in intestinal failure patients","volume":"27","author":"Nikoupour","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.coph.2022.102240_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/j.2040-4603.2018.tb00039.x","article-title":"Glucagon-like peptide-2 and the regulation of intestinal growth and function","volume":"8","author":"Brubaker","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.coph.2022.102240_bib16","first-page":"7","article-title":"Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome","volume":"23","author":"Kunkel","year":"2011","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.coph.2022.102240_bib17","article-title":"Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study","author":"Hvistendahl","year":"2016","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17474124.2019.1569514","article-title":"Emerging treatments for short bowel syndrome in adult patients","volume":"13","author":"Billiauws","year":"2019","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2022.102240_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/biomedicines9040383","article-title":"GLP-1 and intestinal diseases","volume":"9","author":"Hunt","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.coph.2022.102240_bib20","first-page":"6","article-title":"The new place of enterohormones in intestinal failure","volume":"23","author":"Daoud","year":"2020","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.coph.2022.102240_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102240_bib22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2147\/TCRM.S166081","article-title":"Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome","volume":"14","author":"Chen","year":"2018","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.coph.2022.102240_bib23","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.coph.2022.102240_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ncp.10092","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel Syndrome\u2212Associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.coph.2022.102240_bib25","series-title":"Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure","author":"Jeppesen","year":"2018"},{"key":"10.1016\/j.coph.2022.102240_sref26","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_sref28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clnesp.2021.03.011","article-title":"Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support","volume":"43","author":"Chen","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.coph.2022.102240_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jpen.1838","article-title":"Long-term outcomes with teduglutide from a single center","volume":"45","author":"Puello","year":"2021","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ajcn\/nqaa412","article-title":"Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure","volume":"113","author":"Martin","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib31","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1016\/j.clnu.2021.02.011","article-title":"Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: a systematic analysis of a single centre cohort","volume":"40","author":"Pironi","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib32","doi-asserted-by":"crossref","first-page":"106270","DOI":"10.1016\/j.ijscr.2021.106270","article-title":"Bridging intestinal failure with Teduglutide \u2013 a case report","volume":"86","author":"Schlager","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.coph.2022.102240_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gtc.2007.01.007","article-title":"Growth factors in short-bowel syndrome patients","volume":"36","author":"Jeppesen","year":"2007","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.coph.2022.102240_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0261-5614(03)00042-6","article-title":"Quality of life and concerns in patients with short bowel syndrome","volume":"22","author":"Carlsson","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/00365520802078325","article-title":"Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms","volume":"43","author":"Kalaitzakis","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.coph.2022.102240_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jpen.1588","article-title":"Impact of teduglutide on quality of life among patients with short bowel syndrome and intestinal failure","volume":"44","author":"Chen","year":"2020","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820905766","article-title":"Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials","volume":"13","author":"Pape","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.coph.2022.102240_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCG.0000000000000604","article-title":"Safety and efficacy of teduglutide (gattex) in patients with Crohn's disease and need for parenteral support due to short bowel syndrome\u2013associated intestinal failure","volume":"51","author":"Kochar","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.coph.2022.102240_bib39","article-title":"De novo development of hamartomatous duodenal polyps in a patient with short bowel syndrome during teduglutide therapy: a case report","author":"Ukleja","year":"2017","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_sref40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jpen.1982","article-title":"De novo development of distal jejunal and duodenal adenomas after 41 Months of teduglutide treatment in a patient with short-bowel syndrome: a case report","volume":"45","author":"Pevny","year":"2021","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib41","article-title":"Characterization of American teduglutide consumers from 2015 to 2020: a large database study","author":"Loutfy","year":"2021","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib42","series-title":"A\u00a0prospective, multi-center registry for patients with short bowel syndrome","author":"Shire","year":"2021"},{"key":"10.1016\/j.coph.2022.102240_bib43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of Glepaglutide, a long-acting glucagon-like peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.119.262238","article-title":"Pharmacological characterization of Apraglutide, a novel long-acting peptidic glucagon-like peptide-2 agonist, for the treatment of short bowel syndrome","volume":"373","author":"Hargrove","year":"2020","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2022.102240_sref45","article-title":"Apraglutide, a novel glucagon-like peptide 2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial","author":"Eliasson","year":"2021","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib46","series-title":"Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial","author":"Naimi","year":"2019"},{"key":"10.1016\/j.coph.2022.102240_bib47","article-title":"Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel","author":"Reiner","year":"2021","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2022.102240_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000604","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study","volume":"8","author":"Naimi","year":"2021","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:35Z","timestamp":1761461855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489222000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"alternative-id":["S1471489222000674"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102240","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-modifying therapies in short bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102240"}}